Meaningful endpoints for therapies approved for hematologic malignancies

B. Douglas Smith, Amy E. DeZern, Alex W. Bastian, Brian G.M. Durie

Research output: Contribution to journalComment/debatepeer-review

Fingerprint Dive into the research topics of 'Meaningful endpoints for therapies approved for hematologic malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences